{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:33:12Z","timestamp":1785346392182,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Open Research Fund Program of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University","award":["No. CPHN202301"],"award-info":[{"award-number":["No. CPHN202301"]}]},{"name":"Changzhou Medical young talent science and technology project","award":["Lcyx2024006"],"award-info":[{"award-number":["Lcyx2024006"]}]},{"name":"the Scientific Research Project of Jiangsu Commission of Health","award":["No. Yl2023010"],"award-info":[{"award-number":["No. Yl2023010"]}]},{"name":"the Science and Technology Project for Young Talents of Changzhou Commission of Health","award":["No. QN202335"],"award-info":[{"award-number":["No. QN202335"]}]},{"name":"the Changzhou Medical Key Discipline Construction Fund","award":["No. CZXK202222"],"award-info":[{"award-number":["No. CZXK202222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The benefits of improving coverage and timeliness of varicella vaccination need to be quantified in countries where varicella vaccine (VarV) has not yet been included in national immunization programs. This longitudinal study analyzed the vaccine effectiveness (VE) of the varicella vaccination program implemented in Changzhou City during the transitional period (2017\u20132022).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the Immunization Information System and National Notifiable Infectious Disease Surveillance System registry data, this retrospective case-cohort study assessed the VEs of varicella vaccination for Changzhou children born from 2016 to 2021. The subcohort was sampled using inverse probability weighting for the survival analysis design to evaluate the VEs under different dosages and cost types, eliminating confounding by age and location area. Sensitivity analysis for the exclusion part assessed the study's robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5,172 children (1.12%) were sampled to the subcohort for studies, including 2,299 cases. VEs significantly rose with each successive dose, reaching 82.54% and 97.91%. VEs were lower for the single-dose subgroups until 2020, with significant increases in VEs in all subgroups in 2020 and after that. Most children who did not benefit from the \u201c1\u20134\u201d Vaccination Program had lower VEs due to delayed vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Improving 2-dose VarV vaccine coverage and timely vaccination could enhance the immune barrier for susceptible children. During the transitional period, the \u201c1\u20134\u201d Vaccination Program of VarV positively impacted coverage and timeliness in Changzhou.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-21348-9","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T07:37:46Z","timestamp":1737099466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017\u20132022): a registry-based case-cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Suting","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"21348_CR1","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"21348_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3345\/cep.2021.01564","volume":"65","author":"YH Lee","year":"2022","unstructured":"Lee YH, Choe YJ, Lee J, Kim E, Lee JY, Hong K, Yoon Y, Kim YK. Global varicella vaccination programs. Clin Exp Pediatr. 2022;65(12):555\u201362.","journal-title":"Clin Exp Pediatr"},{"key":"21348_CR3","unstructured":"Varicella and herpes zoster vaccines: WHO position paper.\u00a0https:\/\/www.who.int\/publications\/i\/item\/who-wer-8925-265-288."},{"key":"21348_CR4","unstructured":"Table 2: Summary of WHO position papers - Recommended routine immunizations for children.\u00a0https:\/\/www.who.int\/docs\/default-source\/immunization\/tables\/immunization-routine-table2.pdf."},{"key":"21348_CR5","unstructured":"WHO position paper: pneumococcal conjugate vaccines in infants and children under 5 years of age. https:\/\/www.who.int\/publications\/i\/item\/10665-310968."},{"issue":"Suppl 5","key":"21348_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/1469-0691.12580","volume":"20","author":"P Carrillo-Santisteve","year":"2014","unstructured":"Carrillo-Santisteve P, Lopalco PL. Varicella vaccination: a laboured take-off. Clin Microbiol Infect. 2014;20(Suppl 5):86\u201391.","journal-title":"Clin Microbiol Infect"},{"key":"21348_CR7","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1093\/infdis\/jiac214","volume":"226","author":"J Leung","year":"2022","unstructured":"Leung J, Lopez A, Marin M. Changing epidemiology of varicella outbreaks in the United States during the varicella vaccination program, 1995\u20132019. J Infect Dis. 2022;226:S400\u20136.","journal-title":"J Infect Dis"},{"issue":"28","key":"21348_CR8","doi-asserted-by":"publisher","first-page":"45612","DOI":"10.18632\/oncotarget.17317","volume":"8","author":"C Yue","year":"2017","unstructured":"Yue C, Li Y, Wang Y, Liu Y, Cao L, Zhu X, Martin K, Wang H, An Z. The varicella vaccination pattern among children under 5 years old in selected areas in China. Oncotarget. 2017;8(28):45612\u20138.","journal-title":"Oncotarget"},{"issue":"12","key":"21348_CR9","doi-asserted-by":"publisher","first-page":"e1016","DOI":"10.1016\/S2468-2667(23)00248-7","volume":"8","author":"H Zhang","year":"2023","unstructured":"Zhang H, Lai X, Patenaude BN, Jit M, Fang H. Adding new childhood vaccines to China\u2019sNational Immunization Program: evidence, benefits, and priorities. Lancet Public Health. 2023;8(12):e1016\u201324.","journal-title":"Lancet Public Health"},{"key":"21348_CR10","first-page":"100639","volume":"32","author":"H Feng","year":"2023","unstructured":"Feng H, Zhang H, Ma C, Zhang H, Yin D, Fang H. National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. Lancet Reg Health West Pac. 2023;32:100639.","journal-title":"Lancet Reg Health West Pac"},{"issue":"52","key":"21348_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.46234\/ccdcw2023.218","volume":"5","author":"M Wang","year":"2023","unstructured":"Wang M, Li X, You M, Wang Y, Liu X, Li Z, Zhao W, Jiang Z, Hu Y, Yin D. Epidemiological characteristics of varicella outbreaks - China, 2006\u20132022. China CDC Wkly. 2023;5(52):1161\u20136.","journal-title":"China CDC Wkly"},{"issue":"20","key":"21348_CR12","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.vaccine.2020.01.087","volume":"38","author":"L Suo","year":"2020","unstructured":"Suo L, Lu L, Zhao D, Pang X. Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011\u20132017. Vaccine. 2020;38(20):3690\u20136.","journal-title":"Vaccine"},{"issue":"11","key":"21348_CR13","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/vaccines11111674","volume":"11","author":"L Shi","year":"2023","unstructured":"Shi L, Lu J, Sun X, Li Z, Zhang L, Lu Y, Yao Y. Impact of varicella immunization and public health and social measures on varicella incidence: insights from surveillance data in Shanghai, 2013\u20132022. Vaccines (Basel). 2023;11(11):1674.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"21348_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/21645515.2020.1769395","volume":"17","author":"Y Xu","year":"2021","unstructured":"Xu Y, Liu Y, Zhang X, Zhang X, Du J, Cai Y, Wang J, Che X, Gu W, Jiang W, et al. Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019. Hum Vaccin Immunother. 2021;17(1):211\u20136.","journal-title":"Hum Vaccin Immunother"},{"key":"21348_CR15","doi-asserted-by":"publisher","first-page":"1039537","DOI":"10.3389\/fpubh.2022.1039537","volume":"10","author":"M Shu","year":"2022","unstructured":"Shu M, Zhang D, Ma R, Yang T, Pan X. Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: a retrospective observational study. Front Public Health. 2022;10:1039537.","journal-title":"Front Public Health"},{"issue":"12","key":"21348_CR16","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1080\/21645515.2021.1982281","volume":"17","author":"P Hu","year":"2021","unstructured":"Hu P, Yang F, Li X, Wang Y, Xiao T, Li H, Wang W, Guan J, Li S. Effectiveness of one-dose versus two-dose varicella vaccine in children in Qingdao, China: a matched case-control study. Hum Vaccin Immunother. 2021;17(12):5311\u20135.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"21348_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/vaccines10101745","volume":"10","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu N, Zhang J, Xu J, Wang W, Xiao J, Wang T, Luan L, Zhang Y. Epidemiological characteristics of varicella under different immunisation strategies in Suzhou Prefecture, Jiangsu Province. Vaccines (Basel). 2022;10(10):1745.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"21348_CR18","doi-asserted-by":"publisher","first-page":"2246369","DOI":"10.1080\/07853890.2023.2246369","volume":"55","author":"L Wang","year":"2023","unstructured":"Wang L, Yang X, Wang X, Shi P, Zhang X. Assessing vaccine effectiveness for varicella in Wuxi, China: a time-series analysis. Ann Med. 2023;55(2):2246369.","journal-title":"Ann Med"},{"issue":"11","key":"21348_CR19","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1080\/21645515.2021.1958608","volume":"17","author":"Q Wang","year":"2021","unstructured":"Wang Q, Xiu S, Yang L, Huang J, Cui T, Shi N, Wang X, Shen Y, Chen E, Lu B, et al. Economic evaluation of varicella vaccination strategies in Jiangsu province, China: a decision-tree Markov model. Hum Vaccin Immunother. 2021;17(11):4194\u2013202.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"21348_CR20","doi-asserted-by":"publisher","first-page":"2211465","DOI":"10.1080\/21645515.2023.2211465","volume":"19","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhang Y, Yu J, Dong C, Zhang J, Liu N, Qian C, Luan L. Seroprevalence rates in children aged 3\u20136 years after implementing a two-dose varicella vaccination: a observational study. Hum Vaccin Immunother. 2023;19(1):2211465.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"21348_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/tropicalmed8010017","volume":"8","author":"X Sun","year":"2022","unstructured":"Sun X, Dai C, Wang K, Liu Y, Jin X, Wang C, Yin Y, Ding Z, Lu Z, Wang W, et al. A dynamic compartmental model to explore the optimal strategy of varicella vaccination: an epidemiological study in Jiangsu Province, China. Trop Med Infect Dis. 2022;8(1):17.","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"21348_CR22","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1186\/s12889-023-16304-4","volume":"23","author":"L Qiu","year":"2023","unstructured":"Qiu L, Liu S, Zhang M, Zhong G, Peng S, Quan J, Lin H, Hu X, Zhu K, Huang X, et al. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023;23(1):1875.","journal-title":"BMC Public Health"},{"key":"21348_CR23","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1017\/S0950268820000667","volume":"148","author":"W Qin","year":"2020","unstructured":"Qin W, Meng X, Zhang L, Wang Y, Xu X, Li K, Xie S. The impact of long-term moderate level of vaccination coverage for epidemiology of varicella in Lu\u2019an, China: should we change immunisation strategy now? Epidemiol Infect. 2020;148:e74.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"21348_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/21645515.2015.1012015","volume":"11","author":"Y Hu","year":"2015","unstructured":"Hu Y, Luo S, Tang X, Lou L, Chen Y, Guo J. Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China. Hum Vaccin Immunother. 2015;11(3):761\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"21348_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/21645515.2020.1772620","volume":"17","author":"Y He","year":"2021","unstructured":"He Y, Liu Y, Dai B, Zhao L, Lin J, Yang J, Yu H. Assessing vaccination coverage, timeliness, and its temporal variations among children in a rural area in China. Hum Vaccin Immunother. 2021;17(2):592\u2013600.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"21348_CR26","first-page":"698","volume":"23","author":"A Liu","year":"2017","unstructured":"Liu A, Sun T. Meta-analysis of varicella vaccination rates in Chinese children. Chin J Vaccines Immunization. 2017;23(6):698\u2013704.","journal-title":"Chin J Vaccines Immunization"},{"issue":"01","key":"21348_CR27","first-page":"33","volume":"46","author":"K Xuan","year":"2023","unstructured":"Xuan K, Li T, Tang J. A meta-analysis of varicella vaccine 2nd dose coverage among school-age children in China. Int J Biol Prod. 2023;46(01):33\u20139.","journal-title":"Int J Biol Prod"},{"issue":"16","key":"21348_CR28","first-page":"2246","volume":"40","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Han C, Wu D, Zhang Y, Lv X. Epidemiological characteristics analysis of varicella in Changzhou City from 2018 to 2022. Occupation Health. 2024;40(16):2246\u201350.","journal-title":"Occupation Health"},{"issue":"3","key":"21348_CR29","first-page":"195","volume":"21","author":"EJ Chow","year":"2023","unstructured":"Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21(3):195\u2013210.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"21348_CR30","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.vaccine.2019.11.069","volume":"38","author":"I Mack","year":"2020","unstructured":"Mack I, Erlanger TE, Lang P, Sinniger P, Perisa D, Heininger U. Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study. Vaccine. 2020;38(6):1444\u20139.","journal-title":"Vaccine"},{"issue":"4","key":"21348_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jclinepi.2006.06.022","volume":"60","author":"NC Onland-Moret","year":"2007","unstructured":"Onland-Moret NC. van der AD, van der Schouw YT, Buschers W, Elias SG, van Gils CH, Koerselman J, Roest M, Grobbee DE, Peeters PH: Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol. 2007;60(4):350\u20135.","journal-title":"J Clin Epidemiol"},{"key":"21348_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12874-015-0104-0","volume":"16","author":"RH Keogh","year":"2016","unstructured":"Keogh RH, Mangtani P, Rodrigues L, Nguipdop Djomo P. Estimating time-varying exposure-outcome associations using case-control data: logistic and case-cohort analyses. BMC Med Res Methodol. 2016;16:2.","journal-title":"BMC Med Res Methodol"},{"key":"21348_CR33","unstructured":"Health JCo. Health and family planning Commission development programme of Jiangsu. The notice on strengthening varicella surveillance and reporting. 2017."},{"issue":"1","key":"21348_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/21645515.2017.1372069","volume":"14","author":"G Kang","year":"2018","unstructured":"Kang G, Zhou M, Wang Z, Yu J, Tang F. Ten years of experience and progress of electronic immunization registry system in Jiangsu Province. China Hum Vaccin Immunother. 2018;14(1):163\u20134.","journal-title":"China Hum Vaccin Immunother"},{"key":"21348_CR35","doi-asserted-by":"crossref","unstructured":"Dorsey AF. Urbanization and infectious disease. Am J Hum Biol. 2025;37:e24197.","DOI":"10.1002\/ajhb.24197"},{"issue":"1","key":"21348_CR36","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1186\/s12889-024-20537-2","volume":"24","author":"Z Li","year":"2024","unstructured":"Li Z, Meng F, Wu B, Kong D, Geng M, Qiu X, Cao Z, Li T, Su Y, Liu S. Reviewing the progress of infectious disease early warning systems and planning for the future. BMC Public Health. 2024;24(1):3080.","journal-title":"BMC Public Health"},{"issue":"1","key":"21348_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/A:1009661900674","volume":"6","author":"O Borgan","year":"2000","unstructured":"Borgan O, Langholz B, Samuelsen SO, Goldstein L, Pogoda J. Exposure stratified case-cohort designs. Lifetime Data Anal. 2000;6(1):39\u201358.","journal-title":"Lifetime Data Anal"},{"key":"21348_CR38","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1002\/sim.6215","volume":"33","author":"J Cai","year":"2014","unstructured":"Cai J, Zeng D. Sample size\/power calculation for stratified case-cohort design. Stat Med. 2014;33:3973.","journal-title":"Stat Med"},{"key":"21348_CR39","first-page":"028","volume":"003","author":"Z Pinpin","year":"2022","unstructured":"Pinpin Z, Dan W, Yixing L, Hui H, Jianyi YYZ. Application of case-cohort studies in the evaluation of vaccine protection effects. Chin J Vaccines Immunization. 2022;003:028.","journal-title":"Chin J Vaccines Immunization"},{"issue":"Suppl 4","key":"21348_CR40","doi-asserted-by":"publisher","first-page":"S425","DOI":"10.1093\/infdis\/jiac299","volume":"226","author":"ED Shapiro","year":"2022","unstructured":"Shapiro ED, Marin M. The effectiveness of varicella vaccine: 25 years of postlicensure experience in the United States. J Infect Dis. 2022;226(Suppl 4):S425\u201330.","journal-title":"J Infect Dis"},{"issue":"7","key":"21348_CR41","first-page":"1138","volume":"41","author":"ZJZ Zhang","year":"2020","unstructured":"Zhang ZJZ, Suo LD, Zhao D, Pan JB, Lu L. Systematic reviews and evidence quality assessment on effectiveness of 1 dose varicella attenuated live vaccine for healthy children aged 1\u201312 years in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(7):1138\u201344.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"21348_CR42","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1186\/s12889-023-17098-1","volume":"23","author":"F Moek","year":"2023","unstructured":"Moek F, Siedler A. Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006\u20132022. BMC Public Health. 2023;23(1):2191.","journal-title":"BMC Public Health"},{"issue":"5","key":"21348_CR43","doi-asserted-by":"publisher","first-page":"2085468","DOI":"10.1080\/21645515.2022.2085468","volume":"18","author":"J Suh","year":"2022","unstructured":"Suh J, Choi JK, Lee J, Park SH. Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling. Hum Vaccin Immunother. 2022;18(5):2085468.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"21348_CR44","doi-asserted-by":"publisher","first-page":"2224075","DOI":"10.1080\/21645515.2023.2224075","volume":"19","author":"B Liu","year":"2023","unstructured":"Liu B, Li X, Yuan L, Sun Q, Fan J, Jing Y, Meng S. Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City. Hum Vaccin Immunother. 2023;19(2):2224075.","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"21348_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/14760584.2021.1963236","volume":"20","author":"Z Li","year":"2021","unstructured":"Li Z, Yao Y, Lu X, Liu J, Huang Z, Sun X, Lu Y. Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai. China Expert Rev Vaccines. 2021;20(9):1177\u201383.","journal-title":"China Expert Rev Vaccines"},{"issue":"3","key":"21348_CR46","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","volume":"28","author":"M Spackova","year":"2010","unstructured":"Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28(3):686\u201391.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21348-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:15:34Z","timestamp":1737101734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21348-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21348"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21348-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4241764\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was undertaken in accordance with the Declaration of Helsinki. Data used in this study were obtained from the immunization information system and the National Notifiable Disease Surveillance System, and all data were unidentified. And the protocol was approved by the Ethics Committee of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University, and it was found that utilization of disease surveillance did not require informed consent, and the need for informed consent was waived by the Ethics Committee of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}